GM1 Delivery to the CSF Via the Olfactory Pathway

Author： Kumbale R.   Frey W. H.   Wilson S.   Rahman Y. E.  

Publisher： Informa Healthcare

ISSN： 1521-0464

Source： Drug Delivery, Vol.6, Iss.1, 1999-01, pp. : 23-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delivery of Brain-Derived Neurotrophic Factor via Nose-to-Brain Pathway

By Vaka Siva   Murthy Sathyanarayana   Balaji Anna   Repka Michael  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 441-447

Springer Publishing Company

Access to resources Recommend Favorite

GM-CSF beneficial in idiopathic alveolar proteinosis

By  

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

GM-CSF may be a novel strategy for Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Carbamazepine Mucoadhesive Nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa

By Samia Omar   Hanan Refai   Kamal El Tahir  

Drug Delivery, Vol. 19, Iss. 1, 2012-01 ,pp. : 58-67

Informa Healthcare

Access to resources Recommend Favorite

Immobilisation of GM-CSF onto particulate vaccine carrier systems

By Mandal B.   Kempf M.   Merkle H.P.   Walter E.  

International Journal of Pharmaceutics, Vol. 269, Iss. 1, 2004-01 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite